Operating Income Summary of Faes Farma, S.A.

Faes Farma, S.A.'s latest annual operating income in 2023 was 185.28 Million EUR , up 1.91% from previous year.
Faes Farma, S.A.'s latest quarterly operating income in 2024 Q2 was 32.49 Million EUR , up 78.19% from previous quarter.
Faes Farma, S.A. reported an annual operating income of 101.92 Million EUR in 2022, up 3.54% from previous year.
Faes Farma, S.A. reported an annual operating income of 98.44 Million EUR in 2021, up 8.43% from previous year.
Faes Farma, S.A. reported a quarterly operating income of 35.91 Million EUR for 2024 Q1, up 0.49% from previous quarter.
Faes Farma, S.A. reported a quarterly operating income of 103.86 Million EUR for 2023 FY, up 1.91% from previous quarter.

Annual Operating Income Chart of Faes Farma, S.A. (2023 - 2003)

Historical Annual Operating Income of Faes Farma, S.A. (2023 - 2003)

Year	Operating Income	Operating Income Growth
2023	185.28 Million EUR	1.91%
2022	101.92 Million EUR	3.54%
2021	98.44 Million EUR	8.43%
2020	90.78 Million EUR	15.2%
2019	78.8 Million EUR	27.09%
2018	62 Million EUR	25.66%
2017	49.34 Million EUR	2.84%
2016	47.98 Million EUR	14.67%
2015	41.84 Million EUR	15.65%
2014	36.18 Million EUR	26.18%
2013	28.67 Million EUR	25.43%
2012	22.86 Million EUR	53.98%
2011	14.84 Million EUR	-36.23%
2010	23.28 Million EUR	65.08%
2009	14.1 Million EUR	-47.69%
2008	26.96 Million EUR	27.25%
2007	21.18 Million EUR	-6.45%
2006	22.64 Million EUR	-0.47%
2005	22.75 Million EUR	-27.64%
2004	31.44 Million EUR	26.79%
2003	24.8 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	32.49 Million EUR	78.19%
2024 Q1	35.91 Million EUR	0.49%
2023 FY	103.86 Million EUR	1.91%
2023 Q3	25.42 Million EUR	-14.76%
2023 Q4	35.74 Million EUR	40.57%
2023 Q1	32.54 Million EUR	107.67%
2023 Q2	29.82 Million EUR	-8.36%
2022 Q2	30.71 Million EUR	-2.82%
2022 Q3	23.93 Million EUR	-22.08%
2022 Q4	15.67 Million EUR	-34.51%
2022 Q1	31.6 Million EUR	127.74%
2022 FY	101.92 Million EUR	3.54%
2021 Q2	28.73 Million EUR	10.88%
2021 FY	98.44 Million EUR	8.43%
2021 Q4	13.87 Million EUR	-50.8%
2021 Q3	28.2 Million EUR	-1.86%
2021 Q1	25.91 Million EUR	66.96%
2020 FY	90.78 Million EUR	15.2%
2020 Q1	25.85 Million EUR	52.15%
2020 Q2	34.15 Million EUR	32.1%
2020 Q3	16.77 Million EUR	-50.88%
2020 Q4	15.52 Million EUR	-7.47%
2019 Q3	16.99 Million EUR	-27.41%
2019 Q2	23.41 Million EUR	15.99%
2019 FY	78.8 Million EUR	27.09%
2019 Q1	20.18 Million EUR	30.98%
2019 Q4	16.99 Million EUR	0.0%
2018 Q2	16.91 Million EUR	7.07%
2018 Q4	15.4 Million EUR	10.98%
2018 FY	62 Million EUR	25.66%
2018 Q1	15.8 Million EUR	66.86%
2018 Q3	13.88 Million EUR	-17.93%
2017 Q3	15.61 Million EUR	37.15%
2017 FY	49.34 Million EUR	2.84%
2017 Q1	12.6 Million EUR	17.58%
2017 Q4	9.46 Million EUR	-39.36%
2017 Q2	11.38 Million EUR	-9.64%
2016 FY	47.98 Million EUR	14.67%
2016 Q4	10.71 Million EUR	-17.33%
2016 Q3	12.96 Million EUR	2.04%
2016 Q2	12.7 Million EUR	14.45%
2016 Q1	11.1 Million EUR	14.24%
2015 Q2	11.35 Million EUR	24.78%
2015 Q3	11.17 Million EUR	-1.63%
2015 Q4	9.71 Million EUR	-13.02%
2015 FY	41.84 Million EUR	15.65%
2015 Q1	9.1 Million EUR	8.54%
2014 Q3	9.15 Million EUR	-17.07%
2014 Q4	8.38 Million EUR	-8.38%
2014 Q2	11.03 Million EUR	51.52%
2014 FY	36.18 Million EUR	26.18%
2014 Q1	7.28 Million EUR	74.78%
2013 Q2	5.75 Million EUR	-30.62%
2013 Q3	8.44 Million EUR	46.65%
2013 Q4	4.16 Million EUR	-50.65%
2013 FY	28.67 Million EUR	25.43%
2013 Q1	8.29 Million EUR	256.03%
2012 Q1	6.52 Million EUR	582.68%
2012 Q3	9.96 Million EUR	157.91%
2012 FY	22.86 Million EUR	53.98%
2012 Q4	2.33 Million EUR	-76.6%
2012 Q2	3.86 Million EUR	-40.76%
2011 Q1	8.93 Million EUR	0.0%
2011 Q4	-1.35 Million EUR	-127.48%
2011 Q3	4.91 Million EUR	109.19%
2011 FY	14.84 Million EUR	-36.23%
2011 Q2	2.35 Million EUR	-73.69%
2010 Q1	9.4 Million EUR	0.0%
2010 FY	23.28 Million EUR	65.08%
2010 Q2	5.86 Million EUR	-37.63%
2009 FY	14.1 Million EUR	-47.69%
2008 FY	26.96 Million EUR	27.25%
2007 FY	21.18 Million EUR	-6.45%
2006 FY	22.64 Million EUR	-0.47%
2005 FY	22.75 Million EUR	-27.64%
2004 FY	31.44 Million EUR	26.79%
2003 FY	24.8 Million EUR	0.0%

Peer Operating Income Comparison of Faes Farma, S.A.

Name	Operating Income	Operating Income Difference
Almirall, S.A.	-5.26 Million EUR	3619.814%
Laboratorio Reig Jofre, S.A.	10.51 Million EUR	-1662.921%

Global Stocks Search

Faes Farma, S.A. (FAE.MC)

Operating Income Summary of Faes Farma, S.A.

Annual Operating Income Chart of Faes Farma, S.A. (2023 - 2003)

Historical Annual Operating Income of Faes Farma, S.A. (2023 - 2003)

Peer Operating Income Comparison of Faes Farma, S.A.